BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7466618)

  • 21. [Long-term results of the peritoneovenous shunt in the treatment of intractable ascites in cirrhotic patients].
    Dellepiane M; Capussotti L; Polastri R; Mensa G; Marucci MM; Fusario F
    Minerva Med; 1987 May; 78(10):717-20. PubMed ID: 3587721
    [No Abstract]   [Full Text] [Related]  

  • 22. [The Denver shunt in malignant ascites].
    Van Damme H; Vaneerdeweg W; Schoofs E
    Acta Chir Belg; 1985; 85(1):43-52. PubMed ID: 2580408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peritoneovenous shunt: expectations and reality.
    Moskovitz M
    Am J Gastroenterol; 1990 Aug; 85(8):917-29. PubMed ID: 2197858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and new concepts in the designing of peritoneovenous shunts for the treatment of refractory ascites.
    Guzman E; Wigness BD; Dorman FD; Rohde TD; Buchwald H
    ASAIO Trans; 1988; 34(3):805-7. PubMed ID: 3058186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease.
    Tempero MA; Davis RB; Reed E; Edney J
    Cancer; 1985 Jun; 55(11):2718-21. PubMed ID: 3995480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent ascites due to central venous thrombosis after peritoneojugular (LeVeen) shunt.
    Smadja C; Tridard D; Franco D
    Surgery; 1986 Sep; 100(3):535-41. PubMed ID: 3738774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of the Leveen shunt in the treatment of clinically intractable ascites].
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; Arab-Fadul R; Gama-Rodrigues JJ
    Arq Gastroenterol; 1988; 25(3):138-44. PubMed ID: 3255281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes.
    Akimaru K; Ueda Y; Shoji T
    Jpn J Surg; 1988 Sep; 18(5):502-8. PubMed ID: 3230724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of refractory ascites.
    Epstein M
    N Engl J Med; 1989 Dec; 321(24):1675-7. PubMed ID: 2586570
    [No Abstract]   [Full Text] [Related]  

  • 31. [Irritation of the urinary bladder as a rare complication of a LeVeen shunt and its surgical correction].
    Vincze K; Balogh G; Tóth A; Rákász I; Szép E; Muskát J
    Orv Hetil; 1988 Mar; 129(13):671-3. PubMed ID: 3285290
    [No Abstract]   [Full Text] [Related]  

  • 32. Peritoneovenous shunting for ascites.
    Reinhardt GF; Stanley MM
    Surg Gynecol Obstet; 1977 Sep; 145(3):419-24. PubMed ID: 888064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneovenous shunts palliate malignant ascites.
    Edney JA; Hill A; Armstrong D
    Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneovenous shunt (PVS) for malignant ascites. An analysis of outcome.
    Smith DA; Weaver DW; Bouwman DL
    Am Surg; 1989 Jul; 55(7):445-9. PubMed ID: 2742227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Le Veen peritoneo-jugular shunt and the testing of its function].
    Leodolter S; Keiler A; Kreuzer W; Möschl P; Philipp K; Szalay S
    Acta Med Austriaca; 1979; 6(4):133-5. PubMed ID: 552775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients).
    Bories P; Garcia Compean D; Michel H; Bourel M; Capron JP; Gauthier A; Lafon J; Lévy VG; Pascal JP; Quinton A
    J Hepatol; 1986; 3(2):212-8. PubMed ID: 3540097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites.
    Souter RG; Wells C; Tarin D; Kettlewell MG
    Cancer; 1985 May; 55(9):1973-8. PubMed ID: 3978577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites.
    Hobar PC; Turner WW; Valentine RJ
    Surgery; 1987 Feb; 101(2):161-4. PubMed ID: 3810487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of ascitic fluid replacement for prevention of coagulopathy post peritoneovenous shunt. Case report.
    Gagner M; Franco D
    Acta Chir Scand; 1990 Apr; 156(4):337-40. PubMed ID: 2349854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneovenous shunt function 2-6 years after insertion for cirrhotic ascites.
    Stanley MM; VanDrunen M; Greenlee HB
    ASAIO Trans; 1989; 35(2):170-4. PubMed ID: 2730817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.